Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
03:03
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
FAQs
   
Discussion forum - BSH 2020 VIRTUAL
    Topic - Myeloma

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Osteonecrosis of the jaw secondary to bisphosphonate treatment in multiple myeloma - Real world data.  Lewis Vanhinsbergh 1      11/9/2020 12:01:00 PM  
Real world, multi-centre experience of daratumumab monotherapy and response to subsequent treatments in relapsed/refractory myeloma  Jessica Taube 1      11/9/2020 12:01:00 PM  
INSIGHT MM Study Of Routine Clinical Practice In Multiple Myeloma: Analysis Of Duration Of Therapy And Treatment Sequencing In UK Patients  Jill Powell 1      11/9/2020 12:01:00 PM  
The UK Experience of Daratumumab Monotherapy in Relapsed Systemic AL Amyloidosis  Oliver Cohen 1      11/9/2020 12:01:00 PM  
A Single Centre Review of Bortezomib Home-administration in Myeloma Patients: Portsmouth Experience  KG De 1      11/9/2020 12:01:00 PM  
Prevention and management of steroid-induced hyperglycaemia in outpatient myeloma chemotherapy - a tertiary centre audit and quality improvement project.  Pietro Vassallo 1      11/9/2020 12:01:00 PM  
Real world outcomes in multiple myeloma in patients aged 75 and over  David Hopkins 1      11/9/2020 12:01:00 PM  
Lenalidomide with Low-Dose Dexamethasone in Newly DiagnosedTransplant-Ineligible Myeloma. Real-World Experience: Data from a SingleCentre in North Wales, United Kingdom.  Chaminda Arachchilage 1      11/9/2020 12:01:00 PM  
Dynamic changes in serum complements during chemotherapy in patients with Multiple Myeloma and their correlations to disease markers  Sateesh Kumar Nagumantry 1      11/9/2020 12:01:00 PM  
Use of imaging in the management of newly diagnosed patients with myeloma at St. Georges Hospital  Ke Xu 1      11/9/2020 12:01:00 PM  
Real world experience of KPD use in relapsed or refractory myeloma.  Aisling Barrett 1      11/9/2020 12:01:00 PM  
Incorrect specimen collection for investigation of cryoproteins can give mis-leading results  Rachel Wheeler 1      11/9/2020 12:01:00 PM  
Real world experience of tandem autologous stem cell transplant for high risk multiple myeloma at a single UK centre  Huw Richards 1      11/9/2020 12:01:00 PM  
Mature osteoblasts induce myeloma cell death through inhibiting the Sp1-TAK1-Pim2-prosurvival Pathway  Ariunzaya Bat-Erdene 1      11/9/2020 12:01:00 PM  
Impact of Change of Mobilisation Method on Adequacy of Stem Cell Collection in Multiple Myeloma Patients Single Centre Experience  Valarmathi Anandhan 1      11/9/2020 12:01:00 PM  
A Retrospective Review of Antimicrobial Use and Risk Stratification of Patients with Multiple Myeloma Admitted Due to Suspected Infection  Cristina Miralles 1      11/9/2020 12:01:00 PM  
Lenalodamide Induced ITP in myeloma patients with response to steroid and TPO agents - A rare but important event to consider- case series from single institute from south India  Nishith Vaddeboina 1      11/9/2020 12:01:00 PM  
Myeloma in Northland 2016-2017: incidence, risk factors and outcome  Kevin Breen 1      11/9/2020 12:01:00 PM  
Efficacy of Daratumumab Combination Regimen in Patients with Multiple Myeloma: A Combined Analysis of Six Phase III Randomised Controlled Trials  Thomas Erblich 1      11/9/2020 12:01:00 PM  
Myeloma: not just bones at risk of fracture assessing the increasing demand on services  Tanya Freeman 1      11/9/2020 12:01:00 PM  
End of Life Management of Patients with Myeloma at University Hospitals Birmingham  Beena Salhan 1      11/9/2020 12:01:00 PM  
HaemBase Cymru (HBC): An electronic data collection platform for patients treated with haematological malignancies in Wales.  Keith Betts 1      11/9/2020 12:01:00 PM  
INSIGHT MM Study Of Routine Clinical Practice In Multiple Myeloma: Analysis Of Duration Of Therapy And Treatment Sequencing In UK Patients  Jill Powell 1      11/5/2020 2:08:00 PM  
The UK Experience of Daratumumab Monotherapy in Relapsed Systemic AL Amyloidosis  Oliver Cohen 1      11/2/2020 12:23:00 PM  
Real world experience of tandem autologous stem cell transplant for high risk multiple myeloma at a single UK centre  Huw Richards 1      10/31/2020 10:32:00 AM  
       




Most viewed poster for this congress
Poster: 1
Visits: 534
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre: 

Poster most viewed in this topic
Poster: 103
Visits: 129
Title: Lenalidomide with Low-Dose Dexamethasone in Newly DiagnosedTransplant-Ineligible Myeloma. Real-World Experience: Data from a SingleCentre in North Wales, United Kingdom.
Authors: Chaminda Arachchilage , Chaminda Arachchilage:Hematology,GLAN CLWYD HOSPITAL,Rhyl,United Kingdom|Earnest Heartin:Hematology,GLAN CLWYD HOSPITAL,Rhyl,United Kingdom|Christopher Smith:Hematology,GLAN CLWYD HOSPITAL,Rhyl,Unite
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert